Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 8, No 1 (2012) THE COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL VALSARTAN AS A MONOTHERAPY OR IN COMBINATION WITH HYDROCHLOROTHIAZIDE AND BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREE AND METABOLIC SYNDROME Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, V. P. Voronina, L. Yu. Drozdova
"... Aim. To study the efficacy and safety of generic valsartan Valz (Actavis Group, Iceland ..."
 
Vol 7, No 6 (2011) COMPARATIVE EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH MODERATE ARTERIAL HYPERTENSION ACCOMPANIED BY TYPE 2 DIABETES Abstract  similar documents
E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk
"... +indapamide, patients of group B (n=30) — a fixed combination of the generic enalapril+indapamide, patients ..."
 
Vol 6, No 1 (2010) COMPARISON OF NEW GENERIC AND ORIGINAL RAMIPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH CARDIOVASCULAR RISK Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, A. A. Serazhim, V. P. Voronina, M. A. Maksimova, L. Yu. Drozdova, A. V. Zakharova
"... Aim. To compare efficacy of ramipril generic Hartil® (Egis) to original drug Tritace® in patients ..."
 
Vol 9, No 3 (2013) ANTIHYPERTENSIVE EFFICACY AND INFLUENCE ON SEXUAL FUNCTION OF VALSARTAN AND VALSARTAN AND HYDROCHLOROTHIAZIDE COMBINATION IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION Abstract  similar documents
V. I. Podzolkov, A. V. Vigdorchik
"... Aim. To study antihypertensive efficacy and safety of valsartan-based therapy as well as influence ..."
 
Vol 6, No 2 (2010) VALSARTAN IN EVERYDAY CLINICAL PRACTICE IN RUSSIA: ANTIHYPERTENSIVE EFFICACY AND INFLUENCE ON SEXUAL FUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
V. I. Podzolkov, V. A. Bulatov, A. V. Vigdorchik
"... Aim. To study antihypertensive efficacy and safety of valsartan-based therapy (Diovan, Novartis ..."
 
Vol 7, No 1 (2011) THE CHOICE OF THE DRUG AMLODIPINE FOR THE HYPERTENSION TREATMENT FROM THE STANDPOINT OF ECONOMIC FEASIBILITY Abstract  similar documents
S. Yu. Martsevich, N. A. Dmitrieva, A. D. Deev, Yu. V. Lukina, L. A. Sokolova, V. V. Yakusevich
"... Aim. Тo compare the cost-effectiveness of antihypertensive therapy based on a generic and original ..."
 
Vol 6, No 1 (2010) ANTIHYPERTENSIVE EFFICACY OF VALSARTAN IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION: THE FIRST RESULTS OF RUSSIAN MULTICENTER OPEN STUDY Abstract  similar documents
V. I. Podzolkov, V. A. Bulatov, A. V. Vigdorchik
"... Aim. To study antihypertensive efficacy and safety of valsartan (Diovan, Novartis Pharma) as well ..."
 
Vol 13, No 3 (2017) EFFECT OF SACUBITRIL/VALSARTAN ON NATRIURESIS, DIURESIS AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS Abstract  similar documents
Zh. D. Kobalava, S. V. Villevalde, I. A. Meray, O. I. Lukina
"... Aim. To study the effect of sacubitril/valsartan compared with valsartan on natriuresis, diuresis ..."
 
Vol 9, No 3 (2013) ECONOMIC EVALUATION OF COMBINED THERAPY OF ARTERIAL HYPERTENSION BY MARKOV’S MODELING Abstract  similar documents
N. S. Maksimchuk-Kolobova, E. I. Tarlovskaya, S. V. Malchikova
"... randomized into 2 groups. Group V/A was treated with valsartan and amlodipine in fixed-dose combinations ..."
 
Vol 5, No 6 (2009) ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN HYPERTENSIVE PATIENTS WITH AMLODIDINE: ORIGINAL DRUG VERSUS GENERIC Abstract  similar documents
S. Yu. Martsevich, N. A. Dmitrieva, A. D. Deev, L. A. Sokolova, V. V. Jakusevich, J. V. Lukina, M. A. Maximova, A. V. Zaharova, A. A. Serazhim, V. P. Voronina
"... Aim. To evaluate antihypertensive effects of new generic amlodipine (Stamlo M) in comparison ..."
 
Vol 5, No 6 (2009) ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS Abstract  similar documents
N. A. Dmitrieva, S. N. Tolpygina
"... ) in cardiologic practice are presented. The special attention is given to generic drugs of ACA. Their application ..."
 
Vol 7, No 2 (2011) WHAT IS THERAPEUTIC EQUIVALENCE OF GENERIC DRUG AND HOW TO PROVE IT Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, I. V. Vashurina
"... The problem of generic drugs use in clinical practice and confirmation of their therapeutic ..."
 
Vol 14, No 2 (2018) EFFECTS OF SACUBITRIL/VALSARTAN ON THE ARTERIAL STIFFNESS AND LEFT VENTRICULAR-ARTERIAL COUPLING IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION Abstract  similar documents
Zh. D. Kobalava, S. V. Villevalde, I. A. Meray, Е. E. Shkolnikova, O. I. Lukina
"... Aim. To study the effects of sacubitril/valsartan on left ventricular-arterial coupling (LVAC ..."
 
Vol 5, No 1 (2009) PROBLEM OF GENERIC REPLACEMENT: ADVANTAGES AND DISADVANTAGES Abstract  similar documents
S. N. Tolpygina, S. Yu. Martsevich
"... The main differences between original and generic drugs as well as registration criteria ..."
 
Vol 7, No 1 (2011) THE ROLE OF MODERN ANTIPLATELET THERAPY IN PREVENTION OF ATHEROTHROMBOSIS: THE IMPORTANCE OF CLOPIDOGREL AND ITS GENERIC DRUGS Abstract  similar documents
O. V. Gaisenok
"... of the clopidogrel generics appearance and prospects of their use is presented. ..."
 
Vol 15, No 1 (2019) Improving the cognitive functions in the middle-aged patients with essential arterial hypertension after the treatment with amlodipine/valsartan single-pill combination Abstract  similar documents
O. D. Ostroumova, E. V. Borisova, A. I. Kochetkov, T. M. Ostroumova, O. V. Bondarec
"... in single studies. Aim. To investigate the impact of amlodipine/valsartan SPC (A/V SPC) on blood pressure ..."
 
Vol 8, No 2 (2012) PRELIMINARY RESULTS OF COMPARATIVE PHARMACOECONOMIC PROSPECTIVE STUDY OF DIFFERENT THERAPIES OF ARTERIAL HYPERTENSION Abstract  similar documents
E. I. Tarlovskaya, N. S. Maksimchuk, S. V. Malchikova, M. V. Avksentieva
"... randomized into 2 groups. Patients of V/A group received a fixed combination of valsartan and amlodipine ..."
 
Vol 15, No 3 (2019) Effect of the Single-Pill Amlodipine/Valsartan Combination on Hypertrophy and Myocardial Deformation Characteristics in Middle-Aged Patients with Essential Arterial Hypertension Abstract  similar documents
A. I. Kochetkov, E. V. Borisova, O. D. Ostroumova, M. V. Lopukhina, G. V. Piksina
"... Aim. To investigate the impact of amlodipine/valsartan single-pill combination (A/V SPC) on left ..."
 
Vol 14, No 1 (2018) STUDY OF CLINICAL EFFICACY OF ORIGINAL AND GENERIC DRUGS OF IVABRADINE IN PATIENTS WITH STABLE ANGINA (СOMPARATIVE STUDY) Abstract  similar documents
S. V. Povetkin, Ju. V. Luneva
"... Aim. To study the therapeutic efficacy and safety of generic drug of ivabradine in comparison ..."
 
Vol 14, No 6 (2018) The Impact of Valsartan/Amlodipine Single-Pill Combination on Blood Pressure and Vascular Stiffness in Patients with Grade 1-2 Essential Arterial Hypertension Abstract  PDF (Eng)  similar documents
E. V. Borisova, A. I. Kochetkov, O. D. Ostroumova
"... Aim. To investigate the impact of valsartan/amlodipine single-pill combination (V/A SPC ..."
 
Vol 4, No 3 (2008) ESTIMATION OF CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC CARVEDILOLS IN PATIENTS WITH HYPERTENSION OF 1-2 GRADES Abstract  similar documents
E. I. Bambysheva, S. N. Tolpygina, D. F. Guranda, I. E. Koltunov, V. G. Belolipetskaja, S. J. Martsevich
"... ) and of generic (VedicardolR, ≪Synthesis≫, Russia) carvedilols with estimation of their serum level. And to study ..."
 
Vol 7, No 4 (2011) COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH GOUT (CASE REPORT) Abstract  similar documents
O. V. Dralova, M. L. Maksimov
"... antihypertensive drugs with neutral metabolic profile and safety, in particular a combination of valsartan ..."
 
Vol 7, No 2 (2011) A COMPARATIVE STUDY OF THE EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN MONOTHERAPY OR IN COMBINATION WITH S-AMLODIPINE AND INDAPAMIDE IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 DEGREES. RESULTS OF THE CLINICAL RANDOMIZED CROSSOVER STUDY Abstract  similar documents
S. Yu. Martsevich, S. N. Tolpygina, V. P. Voronina, O. V. Lerman, Yu. V. Lukina, N. A. Dmitrieva, I. V. Vashurina
"... Aim. To study the clinical equivalence of original and generic drugs of bisoprolol in patients ..."
 
Vol 9, No 5 (2013) A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL LOW-DOSE BISOPROLOL/HYDROCHLOROTHIAZIDE COMBINATION IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREES. RESULTS OF CLINICAL RANDOMIZED CROSSOVER STUDY Abstract  similar documents
S. Yu. Martsevich, S. N. Tolpygina, A. V. Zakharova, V. P. Voronina, O. V. Lerman, Yu. V. Lukina, N. A. Dmitrieva, N. V. Kiseleva
"... Aim. To study the clinical equivalence of the two low-dose combined drugs on the base of generic ..."
 
Vol 9, No 5 (2013) THE PROBLEM OF MEDICINES INTERCHANGEABILITY. FOCUS ON PERINDOPRIL Abstract  similar documents
A. I. Malyhina, M. V. Zhuravleva, A. K. Starodubtsev, M. L. Maksimov, O. A. Rogacheva
"... Aim. To evaluate the therapeutic equivalence between generic perindopril (Parnavel, LLC Ozone ..."
 
Vol 14, No 6 (2018) Assessment of in Vitro Comparative Dissolution Kinetics of Moxonidine Products as a Factor Potentially Determining Effectiveness of Antihypertensive Treatment Abstract  PDF (Eng)  similar documents
G. V. Ramenskaya, I. E. Shokhin, N. I. Gaponova, V. R. Abdrakhmanov
"... Aim. Investigation of comparative dissolution kinetics of generic medicinal products containing ..."
 
Vol 4, No 5 (2008) COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS Abstract  similar documents
S. N. Tolpygina, S. Y. Martsevich
"... Aim. To assess efficacy and safety of generic simvastatin, Simvahexal, in comparison with original ..."
 
Vol 14, No 3 (2018) TRIPLE ANTIHYPERTENSIVE THERAPY: FOCUS ON EFFICACY AND PROGNOSIS Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, A. V. Starodubova, I. V. Goloborodova, E. A. Smolyarchuk
"... with arterial hypertension. Special focus is given to the body of evidence for the efficacy of valsartan ..."
 
Vol 7, No 5 (2011) COMPARATIVE EFFICACY AND SAFETY OF HYPOLIPIDEMIC THERAPY WITH GENERIC AND ORIGINAL MEDICINAL PRODUCTS OF SIMVASTATIN Abstract  similar documents
E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk
"... Aim. To compare efficacy , safety and pharmacoeconomical characteristics of generic and original ..."
 
Vol 10, No 4 (2014) PHARMACOECONOMIC ANALYSIS OF ANTIHYPERTENSIVE DRUG COMBINATIONS USE Abstract  similar documents
E. I. Tarlovskaya, Y. A. Balandina, N. S. Maximchuk-Kolobova
"... – with double dose. In group B (non-fixed combination of generic enalapril/indapamide) 60% of patients achieved ..."
 
Vol 8, No 1 (2012) EFFICACY OF FIXED COMBINATION OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN COMPLEX THERAPY OF THE PATIENT OF VERY HIGH CARDIOVASCULAR RISK Abstract  similar documents
I. M. Sokolov, N. A. Zheleznyakova
 
Vol 7, No 1 (2011) THERAPEUTIC EQUIVALENCE OF ORIGINAL CLOPIDOGREL (PLAVIX) AND ITS GENERIC (EGITROMB). RESULTS OF COMPARATIVE RANDOMIZED CROSS-OVER BLIND STUDY Abstract  similar documents
V. V. Yakusevich, A. S. Petrochenko, V. A. Simonov, N. Yu. Levshin, A. D. Deev
"... (Plavix) and its generic (Egitromb) in patients of high cardiovascular risk. Material and methods. Thirty ..."
 
Vol 7, No 5 (2011) ECONOMIC BENEFITS OF LEFT VENTRICULAR HYPERTROPHY REGRESSION IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
E. I. Tarlovskaya, N. S. Maksimchuk, S. V. Malchicova, M. V. Avksentieva, I. E. Sapozhnikova, Y. A. Balandina
"... ) regression in patients with arterial hypertension (HT) due to therapy with fixed combination of valsartan ..."
 
Vol 6, No 5 (2010) FIXED COMBINATION OF VALSARTAN AND AMLODIPINE: EFFECTS ON THE LEFT VENTRICULAR HYPERTROPHY REGRESSION, ALBUMINURIA REDUCTION AND ENDOTHELIUM FUNCTION IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME Abstract  similar documents
Ye. I. Tarlovskaya, N. S. Maksimchuk, I. Ye. Sapozhnikova, S. V. Malchikova
"... Aim. To study effects of fixed combination of valsartan and amlodipine on of left ventricular ..."
 
Vol 10, No 1 (2014) CHANGES IN THE PARAMETERS OF 24-HOUR BLOOD PRESSURE MONITORING AND ARTERIAL STIFFNESS IN PATIENTS WITH HYPERTENSION AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE TREATED WITH VALSARTAN Abstract  similar documents
N. A. Karoli, G. R. Dolishnya, A. P. Rebrov
"... ) treated with angiotensin II receptors blocker, valsartan. Material and methods. Men with HT and COPD (n ..."
 
Vol 14, No 2 (2018) PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS Abstract  similar documents
S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov
"... Aim. To perform pharmacoeconomic analysis of CHF therapy with supramolecular sacubitril/valsartan ..."
 
Vol 7, No 6 (2011) A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA Abstract  similar documents
V. P. Voronina, S. N. Tolpygina, N. P. Kutishenko, N. A. Dmitrieva, Yu. V. Lukina, S. Yu. Martsevich
"... Aim. To study efficacy and tolerability of original and generic simvastatin in patients ..."
 
Vol 14, No 6 (2018) The Situation with Valsartan – Commentary of S.A. Boytsov, Chief Cardiologist of Ministry of Health of Russia for the Central, Urals, Siberian and Far Eastern Federal Districts Abstract  PDF (Eng)  similar documents
artilce Editorial
 
Vol 6, No 2 (2010) THE MODERN ASPECTS OF CLOPIDOGREL USE Abstract  similar documents
E. N. Dankovtseva, D. A. Zateyshchikov
"... complications are presented. The results of the comparative trails of original and generic clopidogrel are also ..."
 
Vol 6, No 6 (2010) COMBINATION THERAPY OF HYPERTENSION — A RELIABLE WAY TO TARGET ACHIEVE Abstract  similar documents
Yu. V. Lukina, S. Yu. Martsevich
"... of therapeutic efficacy and safety of combined antihypertensive therapy based on generics are important ..."
 
Vol 8, No 6 (2012) SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES Abstract  similar documents
K. A. Gyamdzhyan, M. L. Maksimov
 
Vol 8, No 2 (2012) COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ORIGINAL AND GENERIC ENALAPRIL IN THE ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
O. P. Bobrova, M. M. Petrova
"... and generic enalaprils in the treatment of the elderly patients with hypertension (HT). Material and Methods ..."
 
Vol 8, No 2 (2012) THE KARDIOKANON STUDY: A WAY TO SETTLE THE SUBJECT OF CLINICAL EQUIVALENCE OF GENERIC AND ORIGINAL DRUGS Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, M. L. Ginzburg, G. V. Matyushin, V. V. Skibitskiy, L. A. Sokolova, A. V. Deev
"... Aim. To compare two therapies based on the use of original or generic drugs in patients ..."
 
Vol 4, No 1 (2008) COMPARISON OF ANTIPLATELET EFFECT AND SAFETY OF ORIGINAL DRUG «ASPIRIN CARDIO» AND GENERIC«ACECARDOL» IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE Abstract  similar documents
N. A. Belolipetskiy, S. N. Tolpygina, O. А. Litinskaya, V. G. Belolipetskaya, S. Yu. Martsevich
"... by therapies. There were not significant inter-group differences. Conclusion. ASA generic medicine Acecardol ..."
 
Vol 3, No 3 (2007) COMPARATIVE EVALUATION OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE Abstract  similar documents
S. N. Tolpygina, E. V. Shilova, S. Y. Martsevich
"... ) and generic (Bisogamma, WORWAG PHARMA GmbH & Co) bisoprolol were investigated in open-label cross-over ..."
 
Vol 12, No 1 (2016) Pharmacoeconomic analysis of heart rate slowing drugs in patients with ischemic heart disease Abstract  similar documents
E. I. Tarlovskaya, T. I. Chudinovskikh
"... Aim. To compare the efficacy and cost/effectiveness ratio of the original and generic bisoprolol ..."
 
Vol 7, No 4 (2011) VALUE OF THERAPEUTIC EQUIVALENCE IN SUBSTITUTION OF ORIGINAL DRUG WITH GENERIC BY EXAMPLE OF FOSINIPRIL Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, Zh. D. Kobalava, E. K. Shavarova
"... Aim. To study the therapeutic equivalence of original and generic fosinopril in patients ..."
 
Vol 6, No 6 (2010) COMPARISON OF ANTIPLATELET EFFICACY OF ORIGINAL AND GENERIC ENTEROSOLUBLE ACETYLSALICYLIC ACID IN PATIENTS WITH HIGH CARDIOVASCULAR RISK. SIMPLE BLIND CROSSED RANDOMIZED CONTROLLED STUDY (IKAR) Abstract  similar documents
S. Yu. Martsevich, S. N. Tolpygina, E. S. Boychenko, R. E. Dubinskaya, Yu. V. Lukina, V. P. Voronina
"... Aim. To compare the antiplatelet efficacy of the original and generic enterosoluble tableted ..."
 
Vol 3, No 5 (2007) CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC AMLODIPINE IN PATIENTS WITH MILD-TO-MODERATE ARTERIAL HYPERTENSION Abstract  similar documents
N. A. Belolipetskiy, S. N. Tolpygina, J. B. Zverkov, V. V. Pisarev, I. E. Koltunov, V. G. Belolipetskaya, S. J. Martsevich
"... with cost of 727 rbl/month for Norvasc therapy. Conclusion. Generic Amlorus showed clinical ..."
 
Vol 8, No 5 (2012) EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN ACHIEVEMENT OF TARGET BLOOD PRESSURE IN DIABETIC PATIENTS Abstract  similar documents
O. A. Koshel'skaya, O. A. Zhuravleva, R. S. Karpov
"... ) or valsartan (80–160 mg/day) in combination with indapamide SR (1.5 mg/day) and amlodipine (5–10 mg/day ..."
 
Vol 6, No 1 (2010) ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES Abstract  similar documents
E. M. Khurs, A. V. Poddubnaya
"... receptor antagonist (ARA), valsartan at the cardiovascular continuum (CVC) stages. Material and methods ..."
 
Vol 4, No 4 (2008) ECONOMIC REASONS FOR GENERIC CHOICE Abstract  similar documents
N. P. Kutishenko, S. Y. Martsevich, S. N. Tolpygina, J. V. Lukina
"... Many generic medicines appear in the pharmaceutical market now. However, they are not always ..."
 
Vol 4, No 1 (2008) ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
"... Guidelines are discussed. Problem of statin choice and problem of equivalence of generic drugs to original ..."
 
Vol 12, No 1 (2016) A comparative study of the efficacy and safety of the original and generic orlistat in obese patients in the PROFIL register Abstract  similar documents
A. V. Zakharova, S. N. Tolpygina, V. P. Voronina, S. Yu. Martsevich
"... Aim. To study the efficacy and safety of generic orlistat in comparison with the original drug ..."
 
Vol 16, No 6 (2020) Monitoring Cardiovascular Medicine Prices as a Tool for Analyzing the Effectiveness of Government Intervetions to Ensure Access to Medicines at the Regional Level Abstract  similar documents
C. M. Razzakova, L. E. Ziganshina
"... . For each name, we studied the prices for the original brand and its lowest-priced generic. We compared ..."
 
Vol 5, No 6 (2009) STATIN GENERICS: EFFICACY AND SAFETY RATIO Abstract  similar documents
V. P. Voronina, A. A. Serazhim, A. V. Zagrebelnyi, S. Yu. Martsevich, S. A. Shalnova
"... choice between original and generic drugs is discussed taking into account efficacy and safety ratio. ..."
 
Vol 8, No 3 (2012) EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES Abstract  similar documents
O. A. Koshel'skaya, O. A. Zhuravleva
"... therapy with valsartan (n=20), 80–160 mg/day , or perindopril (n=21), 5–10 mg/day , in combination ..."
 
Vol 14, No 5 (2018) The Potential of the Volumetric Sphygmography for the Diagnosis of Impaired Arterial Stiffness in Patients with Uncomplicated Arterial Hypertension and Its Possibilities for Evaluation of the Antihypertensive Therapy Effectiveness Abstract  similar documents
E. V. Borisova, A. I. Kochetkov, O. D. Ostroumova
"... with SPC (perindopril arginine/indapamide or valsartan/amlodipine) achieved the target BP level (<140/90 mm ..."
 
Vol 2, No 2 (2006) PROBLEM OF TREATMENT WITH STATINS IN RUSSIA: WILL GENERICS HELP? Abstract  similar documents
S. Y. Martsevich
"... of generic-statins equivalence to original drugs is considered. ..."
 
Vol 13, No 2 (2017) OBJECTIVE AND SUBJECTIVE FACTORS OF MEDICAL DRUG CHOICE Abstract  similar documents
E. B. Babanskaya, L. V. Menshikova
"... were related to the physicians’ choice of the original or generic MD and the factors that influence ..."
 
Vol 15, No 2 (2019) Cardiovascular medicine prices as an indicator of access to medicines and their rational use Abstract  similar documents
C M. Razzakova, L. E. Ziganshina
"... for the original brand drug and its lowest-priced generic. We compared medicine prices with international reference ..."
 
Vol 1, No 1 (2005) ASSESSMENT OF QUALITY OF GENERICS IN CARDIOLOGY: REALITY AND POSSIBILITIES Abstract  similar documents
V. V. Yakusevich
"... Wide presence of original drugs’ copies, the so-called “generics”, on the pharmaceutical market ..."
 
Vol 1, No 3 (2005) EFFICIENCY AND SAFETY ASSESSMENT OF GENERIC ATORVASTATINE IN PATIENTS WITH HYPERLIPIDEMIA Abstract  similar documents
J. E. Semyonova, S. Y. Martsevich, N. V. Perova, A. M. Olferiev, N. P. Kutishenko, N. Y. Ivanenkova, N. A. Dmitrieva, A. A. Serazhim
"... with atorvastatine generic, Tulip, in comparison with simvastatine generic, Vasilip, in hyperlipidemic patients ..."
 
Vol 3, No 2 (2007) ASSESSMENT OF THERAPEUTICAL EQUIVALENCY OF ORIGINAL AND GENERIC INDAPAMIDE IN HYPERTENSIVE PATIENTS BY RANDOMIZED CROSS-OVER STUDY Abstract  similar documents
N. P. Kutishenko, V. V. Yakusevich, A. D. Deev, S. Y. Martsevich
"... Aim. To develop a protocol for comparison of efficacy and safety of original drugs with generic ..."
 
Vol 8, No 4 (2012) THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
L. E. Chekuldaeva, S. V. Obuhova, A. A. Simakov, L. V. Poljaeva, E. I. Rjazanova
 
Vol 10, No 5 (2014) DUAL ANTIPLATELET THERAPY IN THE REAL CLINICAL PRACTICE Abstract  similar documents
G. N. Guseva, T. V. Pavlova, I. L. Voronova, S. M. Chohlunov
"... than 50% of patients received recommended DAPT at that they preferred generic drugs of clopidogrel ..."
 
Vol 10, No 5 (2014) STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE Abstract  similar documents
L. N. Malay
"... equivalence of generic drug with original rosuvastatin are presented. ..."
 
Vol 12, No 2 (2016) COMPARATIVE PHARMACOKINETICS AND EFFECT ON THE HEMODYNAMICS OF ORIGINAL AND GENERIC NEBIVOLOL IN HEALTHY VOLUNTEERS Abstract  similar documents
E. I. Bambysheva, K. V. Isaeva, M. M. Makhinova, D. T. Guranda, V. G. Belolipetskaya
"... of generics into clinical practice requires clear evidence of bioequivalence to the original drug. Aim ..."
 
Vol 6, No 4 (2010) ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM? Abstract  similar documents
D. V. Nebieridze, A. S. Safarian
 
Vol 8, No 2 (2012) UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE Abstract  similar documents
S. Yu. Martsevich, V. P. Voronina, M. L. Ginzburg, N. P. Kutishenko, Yu. N. Polyanskaya, T. G. Kheliya, A. M. Malysheva, S. N. Tolpygina, V. S. Kutuzova, E. A. Gofman, A. D. Deev
 
Vol 2, No 4 (2006) QUALITATIVE DRUG: WHAT SHOULD IT LOOK LIKE? Abstract  similar documents
V. V. Iakusevich
"... reduction is also connected with a huge number (80%) of reproduced drugs (generics). Considerable part among ..."
 
Vol 11, No 4 (2015) EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME Abstract  similar documents
A. V. Rudakova, N. V. Lomakin
"... years. It was assumed that the patients were receiving either generic clopidogrel or ticagrelor for 1 ..."
 
Vol 6, No 4 (2010) COMPARISON OF CLINICAL EFFICACY OF ORIGINAL BISOPROLOL AND ITS GENERIC DRUG IN PATIENTS WITH STABLE ANGINA AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE Abstract  similar documents
N. Yu. Grigorieva, E. G. Sharabrin, A. N. Kuznetsov
"... and its generic in patients with stable angina and concomitant chronic obstructive pulmonary disease (COPD ..."
 
Vol 16, No 5 (2020) Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY) Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko
"... Aim. To perform a pharmacoeconomical assessment of the use of generic statin drugs in patients ..."
 
Vol 14, No 6 (2018) Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study) Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, N. A. Dmitrieva, S. V. Blagodatskikh, O. V. Lerman, T. A. Gomova, S. I. Drozdetsky, V. V. Skibitskiy, E. A. Kudryashov, N. F. Puchinyan
"... Aim. To study adherence to treatment with generic statins prescribed to patients with high and very ..."
 
Vol 9, No 2 (2013) INTERCHANGEABILITY OF MYOCARDIAL CYTOPROTECTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE. DIFFICULT QUESTIONS –SIMPLE SOLUTIONS Abstract  similar documents
Zh. M. Sizova
"... and generic drugs. The study showed clinical equivalence of the generic DeprenormR (Canonpharma Production ..."
 
Vol 13, No 3 (2017) COMBINED ANTIHYPERTENSIVE THERAPY IN REAL CLINICAL PRACTICE. FOCUS ON FIXED COMBINATIONS OF ANTIHYPERTENSIVE DRUGS (According to the Data of Outpatient Registries RECVASA and PROFILE) Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina, A. V. Zagrebelnyy, M. M. Loukianov, A. N. Vorobyev, E. A. Pravkina, N. O. Myasnikova
"... combinations, original and generic AHD. Data on the achievement/non-achievement of target blood pressure (BP ..."
 
Vol 16, No 3 (2020) A Prospective, Initiative, Single-Center Open Post-Registration Comparative Study of Laboratory Efficacy of Various Forms of Acetylsalicylic Acid in a Cardioprotective Dose with Different Composition of Excipients: Results of the SFAIROS Study Abstract  similar documents
N. V. Lomakin, L. I. Buryachkovskaya, D. A. Zolin, V. I. Kazey
"... and pharmacokinetic parameters of branded generic preparations of acetylsalicylic acid (ASA) in buffered form ..."
 
Vol 5, No 4 (2009) PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
"... prevention with statins are briefed. Therapeutic equivalence of statin generics with originator is discussed.  ..."
 
Vol 6, No 4 (2010) EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK Abstract  similar documents
N. V. Perova, E. I. Sokolov, G. N. Shchukina, V. A. Metelskaya
"... . Requirements for generics of one of the widely used statin, simvastatin, are discussed. Data of several studies ..."
 
Vol 14, No 6 (2018) Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation Abstract  PDF (Eng)  similar documents
A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina, D. V. Duplyakov, O. H. Malysheva, I. V. Osipova, T. A. Petrichko, G. I. Kropanin, R. A. Kasimov, D. A. Leon, M. McKee
"... in the private pharmacies. Data were obtained for both original drug and appropriate generics. A list of 25 ..."
 
Vol 6, No 1 (2010) THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE Abstract  similar documents
Yu. V. Lukina, S. Yu. Martsevich
"... ) are presented. Implementation of bisoprolol generics as well as bisoprolol usage in smoking cardiovascular ..."
 
Vol 16, No 5 (2020) Associations of Blood Pressure and Heart Rate and Their Contribution to the Development of Cardiovascular Complications and All-Cause Mortality in the Russian Population of 25-64 Years Abstract  similar documents
S. A. Shalnova, V. A. Kutsenko, A. V. Kapustina, E. B. Yarovaya, Yu. A. Balanova, S. E. Evstifeeva, A. E. Imaeva, S. A. Maksimov, G. A. Muromtseva, N. V. Kulakova, O. N. Kalachikova, T. M. Chernykh, O. A. Belova, G. V. Artamonova, E. V. Indukaeva, Yu. I. Grinshtein, R. A. Libis, D. V. Duplyakov, O. P. Rotar, I. A. Trubacheva, V. N. Serebryakova, A. Yu. Efanov, A. O. Konradi, S. A. Boytsov, O. M. Drapkina
"... <140/90 мм рт.ст. и ЧСС≤80 уд/мин; вторая – АД<140/90><140/90 мм рт.ст. и ЧСС>80 уд/мин; третья – АД ..."
 
Vol 14, No 1 (2018) PROBLEMS OF EVALUATING BLOOD PRESSURE MEASUREMENT IN MODERN CLINICAL TRIALS (THE CASE OF SPRINT STUDY RESULTS) Abstract  similar documents
V. M. Gorbunov
"... мм рт.ст. у пациентов с высоким риском сердечно-сосудистых осложнений (ССО). В исследование был ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF CONTROLLED RELEASE METOPROLOL TARTRATE IN PATIENTS WITH ARTERIAL HYPERTENSION: ERA STUDY RESULTS Abstract  similar documents
O. L. Barbarash, M. V. Zykov
"... 100-150 мг, если не был достигнут целевой уровень АД менее 140/90 мм рт.ст. (менее 130/80 мм рт.ст ..."
 
Vol 16, No 2 (2020) The Effects of Telmisartan and Its Combinations on Office Blood Pressure: Results of Prospective Observational Study TAINA Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, F. T. Ageev, G. S. Anikin, E. Kh. Akhmetzyanova, E. I. Bezuglova, A. B. Bekoeva, N. Yu. Borovkova, N. G. Vinogradova, E. V. Gorbunova, A. A. Goryacheva, E. S. Zhugrova, O. A. Kislyak, S. M. Klyashev, V. P. Kuzmin, A. A. Lipchenko, G. V. Matyushin, E. A. Mikhailova, V. A. Nevzorova, A. G. Obrezan, T. A. Petrichko, M. M. Petrova, A. N. Reider, A. N. Repin, V. I. Sadovoy, N. P. Sanina, A. E. Skripchenko, R. I. Stryuk, I. V. Faiyance, L. A. Khaisheva, N. R. Khasanov, R. A. Khokhlov, E. E. Tsareva, A. L. Cherkashina, I. I. Shaposhnik, I. A. Shelestova, R. N. Shepel, E. V. Shikh, D. A. Yakhontov
"... рт.ст. до 131,4±12,1/80,8±7,3 мм рт.ст. к концу 4-й нед и до 125,3 ±7,6/78,2±6,1 мм рт.ст – к концу ..."
 
Vol 9, No 4 (2013) URAPIDIL: MODERN MEDICINE FOR THE TREATMENT OF HYPERTENSIVE CRISES Abstract  similar documents
A. V. Melekhov, Yu. I. Ostrovskaya
"... с 208 (203-222) мм рт.ст. до 159 (149-180) и до 145 (141-153) мм рт.ст. к 20-й и 220-й мин ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES Abstract  similar documents
A. N. Meshkov
"... rare. Generic atorvastatin 80 mg OD in ATLANTIC study was effective and safe. However efficacy ..."
 
Vol 11, No 3 (2015) RENAL DENERVATION IN THE TREATMENT OF RESISTANT HYPERTENSION: RESULTS OF A ONE-YEAR OBSERVATIONAL STUDY Abstract  similar documents
V. A. Sulimov, A. V. Rodionov, A. A. Svetankova
"... . Результаты. Через 12 мес после проведения РДН офисное систолическое АД (САД) снизилось со 165 до 150 мм рт.ст ..."
 
Vol 11, No 5 (2015) Predictors of atherosclerotic lesions of limb arteries according to cardioangiological screening of the adult population Abstract  similar documents
R. A. Khokhlov, A. E. Gaydashev, N. M. Akhmedzhanov
"... атеросклеротического поражения артерий считались значения │ΔСАДр│≥15 мм рт.ст. или │ΔСАДн│≥15 мм рт.ст., или ЛПИ≤0 ..."
 
Vol 15, No 6 (2019) Russian Trial ALGORITHM: Implementation of Combined Antihypertensive and Hypolipidemic Treatment for Clinical Efficacy Achievement in Routine Clinical Practice Abstract  similar documents
D. A. Napalkov
"... , женщины – 57,8%. Пациенты, у которых была зафиксирована систоло-диастолическая АГ (АД >140/90 мм рт.ст ..."
 
Vol 5, No 5 (2009) EFFICACY AND SAFETY OF VASOACTIVE BETA-BLOCKERS IN ACUTE PHARMACOLOGICAL TEST IN HYPERTENSIVE PATIENTS OF DIFFERENT AGES Abstract  similar documents
O. V. Fedorishina, A. A. Dzizinsky, K. V. Protasov, V. A. Protasova, T. I. Kucherova, E. G. Zakharova, D. D. Baskhaeva, T. S. Sukhoroslova, O. V. Perkova
"... пациентов молодого и среднего возраста выявлено значимое снижение систолического (-6,9 и -6,0 мм рт.ст ..."
 
Vol 4, No 2 (2008) DIHYDROPYRIDINE CALCIUM ANTAGONISTS: THE ROLE IN CURRENT THERAPY OF CARDIO-VASCULAR DISEASES Abstract  similar documents
E. V. Shilova, S. Y. Martsevich
"... on comparison of two amlodipines (original Norvasc and generic Stamlo M) are discussed. ..."
 
Vol 5, No 6 (2009) ORGANOPROTECTIVE EFFECTS OF THE FIXED COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR LISINOPRIL AND DIURETIC HYDROCHLOROTHIAZIDE Abstract  similar documents
E. A. Ryabikhin, M. E. Mozheiko
"... офисного АД с 161,8±18,6/93,9±8,9 мм рт.ст. до 137,3±12,2/84,1±6,5 мм рт.ст. (p<0,05). Наблюдалась ..."
 
Vol 7, No 5 (2011) ARRESTING OF COMPLICATED HYPERTENSIVE CRISES IN THE PHYSICIAN’S PRACTICE: URAPIDIL VALUE AND STUDY RESULTS Abstract  similar documents
G. P. Arutyunov, L. G. Oganezova
"... 157,8±8,3 мм рт.ст. (p<0,05), а диастолическое АД (ДАД) — с 115,7±8,5 до 86,9±9,1 мм рт.ст. (p<0 ..."
 
Vol 5, No 3 (2009) COMPARATIVE CONTROLLED STUDY OF ANTIHYPERTENSIVE EFFICACY AND SAFETY OF CARVEDILOL IN PATIENTS WITH HYPERTENSION AND OBESITY OR DIABETES 2 TYPE (BASED ON RESULTS OF MULTICENTER TRIAL ACCORD) Abstract  similar documents
Yu. V. Yu.V. Lukina, S. Yu. Martsevich, A. D. Deev, S. A. Shalnova
"... снизилось на 24,8 мм рт.ст., а в контрольной - на 21,4 мм рт.ст.; ДАД - на 12,5 мм рт.ст. и 11 мм рт.ст ..."
 
Vol 15, No 2 (2019) Modern Recommendations and Real Clinical Practice: the Results of the SILA Study Abstract  similar documents
O. A. Kislyak, I. I. Chukaeva, V. A. Vygodin
"... % случаев). Средний уровень систолического АД был 1 64,2±11,4 мм рт.ст., диастолического - 94,8±8,1 мм рт.ст ..."
 
Vol 13, No 4 (2017) COMPARATIVE ANALYSIS OF THE EFFICACY OF FIXED-DOSE COMBINATIONS OF AMLODIPINE/LISINOPRIL AND BISOPROLOL/HYDROCHLORTHIAZIDE IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION COMBINED WITH OBESITY AND OVERWEIGHT Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, M. V. Lopukhina
"... -5,4 мм рт.ст., соответственно; p<0,05) и вариабельности САДв дневное время (-2,8±0,8 против -0,9±0 ..."
 
Vol 13, No 2 (2017) STUDY OF THE PARAMETERS OF TOLERABILITY AND ADHERENCE TO THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ARTERIAL HYPERTENSION ON THE BACKGROUND OF TREATMENT WITH FIXED COMBINATION OF RAMIPRIL AND AMLODIPINE (ACCORDING TO THE RESULTS OF OBSERVATIONAL STUDY "GRANAT-2") Abstract  similar documents
S. Y. Martsevich, Yu. V. Lukina, N. P. Kutishenko, V. P. Voronina, N. A. Dmitrieva, A. V. Zakharova, O. V. Lerman, A. A. Garganeyeva, T. A. Gomova, S. A. Drozdetsky, A. I. Chesnikova
"... среднем на 20 мм рт.ст. от исходного уровня, а диастолическое АД – на 10 мм рт.ст. Через 5 мес терапии эти ..."
 
Vol 15, No 6 (2019) Characteristics of Patients with Reproducible Masked Hypertension and its Diagnosis Approach Abstract  similar documents
М. I. Smirnova, V. M. Gorbunov, Ya. N. Koshelyaevskaya, A. D. Deev, D. A. Volkov, N. V. Furman, P. V. Dolotovskaya
"... , клиническое АД меньше 140 и 90 мм рт.ст., отсутствие когда-либо диагноза АГ и приема любых антигипертензивных ..."
 
1 - 100 of 157 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)